Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

The results were stunning. So too was the nationality of the company behind them. Akeso, a biotech firm, is Chinese.

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

AI helps scientists decode a cone snail toxin’s targets, paving the way for safer drug development and ecological research.

Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

Former DeepMind scientist Simon Kohl has raised $50 million for Latent Labs, a London-based AI startup aiming to transform ...

Chemistry labs are also making effective use of AI. Repetitive and time-consuming laboratory tasks are now being performed by ...

focusing on AI and cybernetics in drug development. Phase I involved aligning AI-driven processes with Conduit’s goals, validating proprietary inputs, and analyzing cocrystal candidates.

Insilico Medicine ( “Insilico”) , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today ...